CVS Health posted Q4 sales of $97.71B, with a 23.3% rise in Health Care Benefits revenue. Fiscal 2025 adjusted EPS guidance ...

Pharmacy retailer CVS Health Inc. (NYSE:CVS) is scheduled to report its fourth quarter 2024 earnings on Wednesday,2. Wall ...

Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” fourth quarter 2024 investor ...

Centene’s results buoyed investors after other insurance companies reported out-of-control costs for the quarter.

Wells Fargo analyst Stephen Baxter lowered the firm’s price target on Cigna (CI) to $341 from $370 and keeps an Equal Weight rating on the ...

Equities research analysts at Leerink Partnrs decreased their Q2 2025 earnings per share estimates for The Cigna Group in a ...

Cigna's actual EPS of $6.64 for Q4 fell short of the forecasted $7.79, representing a 14.7% miss. However, revenue of $65.65 billion surpassed expectations by 3.9%, indicating strong top-line ...

Q4 2024 Earnings Call Transcript January 30, 2025 Cigna Corporation misses on earnings expectations. Reported EPS is $6.64 EPS, expectations were $7.84. Operator: Ladies and gentlemen, thank you for ...

Cigna Corp (NYSE:CI) reported its fourth-quarter 2024 earnings, revealing a notable miss on earnings per share (EPS) despite surpassing revenue expectations. The company’s stock reacted negatively in ...